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Abstract
Background: Leishmaniasis includes a wide complex of diseases that affect humans and other mammals, and can
range from a mild cutaneous form to a severe visceral type. The safety of the standard treatment using pentavalent
antimony is a concern due to its toxic effects. The search for alternative, effective and less toxic treatments has led
to the testing of natural products. The present study aimed to evaluate the cytotoxic, leishmanicidal and healing
potential of Arrabidaea chica.
Methods: The crude ethanolic extract, as well as the chloroform, methanol and ethyl acetate fractions of A. chica were
prepared and phytochemical analysis was performed. Cytotoxic evaluation was carried out through MTT colorimetric
assay, and the 50 % cellular cytotoxicity was determined. After that, the effect of the extract and fractions against
Leishmania amazonensis promastigotes, at intervals of 24, 48 and 72 h, was analyzed, and 50 % inhibitory concentration
was determined. The healing effect of the plant was also tested in surgical lesions in Swiss mice skin.
Results: Phytochemical screening showed that the crude extracts contained flavonoids, tannins, anthocyanidins
and chalcones. The leishmanicidal potential of A. chica produced satisfactory results in concentrations of
between 60 and 155.9 μg/mL. Cytotoxic assay revealed a 50 % reduction in viable cells at a concentration of
189.9 μg/mL. The healing results indicated that the treated group exhibited more pronounced signs of lesion
resolution in the early period, but this pattern did not persist throughout the treatment.
Conclusions: The results of the present study demonstrate that A. chica has cytotoxic and leishmanicidal
potential but its healing effect must be better studied.
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Background
Leishmaniasis is a group of diseases that affect several
species of mammals that live in tropical and subtropical
regions. Literature describes more than 20 species of the
protozoan Leishmania that causes leishmaniasis, includ-
ing cutaneous and visceral leishmaniasis [1, 2]. These
clinical forms differ in clinical presentation, morbidity
and mortality [3].
According to the World Health Organization, neglected
diseases are those associated with low social indicators, and
are thus more frequently found in developing countries
where there is a lack of resources aimed at control and treat-
ment and little research into finding an effective solution [4].
Among the clinical forms of the disease, the cutane-
ous, characterized by skin lesions, chiefly in exposed
body parts, is the most common [5]. Depending on the
species of Leishmania, in some patients leishmaniasis
can heal without treatment, while in others diffuse cuta-
neous or mucocutaneous forms can develop [6].
In all clinical forms, pentavalent antimonials have been
used as a mainstay therapy: the available drug for the treat-
ment of leishmaniasis in the United States and Europe is
sodium stibogluconate (Pentostam), while meglumine
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antimonate (Glucantime®) is more used in South America
and Africa [7]. Despite this therapy having been widely
employed since 1912, the mechanism of action is poorly
understood and adverse effects, which include renal and
hepatic toxicity, are severe [8]. Other limitations of this
therapy are the necessity of daily parenteral administration
and the resistance of the drug [2].
These limitations, the vast Brazilian biodiversity and
traditional knowledge has led to the establishment of
research networks to evaluate the leishmanicidal effect
of plants from various biomes, such as the Cerrado and
Amazon. It is therefore very important to perform ex-
periments using natural products in order to identify
new, less toxic, compounds which could be taken orally.
In addition, the Brazilian government has created the
RENISUS (Rede nacional de plantas medicinais de inter-
esse do sistema único de saúde), a list of plants that can
be used in the Unified Health Service, and Arrabidaea
chica is included in this list.
Arrabidaea chica Verlot, popularly known as pariri,
belongs to the Bignoniaceae Family, popularly known as
pariri. It is endemic in almost all of Brazil but is most
frequently found in the Amazon Forest [9] where it is
used to treat skin disease, mulligrubs, anemia, jaundice
and inflammatory reaction [10–12]. Widespread use by
native populations lead researchers from different coun-
tries to evaluate the medicinal properties of this plant,
including its anti-inflammatory [13]; astringent, antioxi-
dant [14, 15]; anti-ulcer [16]; antimicrobial, antifungal
[17, 18] and wound healing [19, 20] effects.
The aim of the present study was to evaluate the
phytochemical effects, wound healing capacity and cyto-
toxicity of Arrabidaea chica, as well to evaluate the ac-
tion of the crude extract and fractions of these plants on
promastigotes of L. amazonensis.
Methods
Ethics committee
The experimental protocol for this study was ap-
proved by the ethics committee for animal research
of the Universidade Estadual do Maranhão (CEUA-UEMA
protocol 26/2009) and by the ethics committee in animal
experimentation of Instituto Oswaldo Cruz - FIOCRUZ/
RJ (CEUA-FIOCRUZ protocol LW72/12).
Plant
Leaf and stem samples of Arrabidaea chica Verlot. were
cultivated and collected in the Atico Seabra Herbarium,
Departmento de Farmácia, Universidade Federal do
Maranhão (São Luís, Maranhão, Brazil). The plant
material was identified by Dr. Ana Zélia Silva and a
voucher specimen was deposited under the number
1067. The plant material was collected between August
and November 2011, which represents the dry season in
this region, with a rainfall rate of 900 mm and an average
temperature of 28 °C.
Preparation of crude extract and fractions
To obtain the crude ethanolic extract, the samples were
dried at 40 °C with forced air circulation. The dried mater-
ial from each part of A. chica was macerated and immersed
in ethyl alcohol, in a proportion of 3:1 (alcohol and plant
material, respectively). In order to obtain the ethanolic ex-
tracts solvent removal was carried out by rotoevaporation,
under reduced pressure at 30 to 40 °C, until the desired
concentrations were achieved. The samples were stored
under refrigeration and protected from light until analysis.
To determine the dry weight of the samples three ali-
quots of 0.5 mL of crude ethanolic extract were used.
The yield of samples was calculated using the total
weight of the powder, the dry weight obtained and the
total final volume of the concentrated extract.
Additionally, the crude ethanolic extracts were fraction-
ated by sequential partition using solvents of increasing
polarity: chloroform, ethyl acetate and methanol. Extrac-
tion was carried out in the solid phase using silica gel,
grail, pistil and approximately 500 mL of each solvent.
Once obtained, the fractions were submitted to leishmani-
cidal and cytotoxic tests. Those that produced satisfactory
results were sent to the Analytical Center of the Universi-
dade de São Paulo (São Paulo, Brazil), to identify the bio-
active compounds through gas chromatography and mass
spectrometry.
Phytochemical analysis
To evaluate the presence of secondary metabolites (sapo-
nins, anthocyanidins, chalcones, phenols, tannins, flavo-
noids, steroids, triterpenoids and anthraquinones), crude
ethanolic extracts of A. chica were solubilized in methanol
(in a concentration of 100 mg/5 mL), according to Costa
and Matos [21, 22].
In vitro cytotoxic assay
Obtaining of peritoneal macrophages and cell culture
Peritoneal macrophages were obtained from 4-week-old
female BALB/c mice, from the Laboratory Animal Breed-
ing Center (CECAL-FIOCRUZ) and kept in the Hélio and
Peggy Pereira Pavilion animal facilitiy, located at the
Oswaldo Cruz Foundation (FIOCRUZ, Rio de Janeiro,
Brazil).
Three mL of 3 % sodium thioglycollate was inoculated
into the peritoneal cavity of the animals and, after 72 h,
were euthanized in a CO2 chamber. For macrophage re-
covery, 5 mL of a cold and sterile pH 7, 2 PBS solution
was injected into the abdominal cavity, followed by mas-
sage and collection of lavage, which was kept in a falcon
tube, placed in an icebox. After collection, the lavage
was analyzed under an optical microscope to verify the
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presence of macrophages and the lack of red blood cells
and bacteria.
Peritoneal lavage was centrifuged at 500 xg for 10 min
at 4 °C. The supernatant was discarded and the cells
resuspended in 1 mL of RPMI 1640 and counted in a
Neubauer chamber. Final macrophage concentration was
standardized at 5x105 cells/well. For cell culture, RPMI
supplemented with 10 % fetal bovine serum, L-glutamine
(20 mM), sodium bicarbonate solution (7.5 %), penicillin
(100 μg/mL) and streptomycin (50 μg/mL) was used, incu-
bated at 37 °C with 5 % CO2.
CC50 determination
Cytotoxicity was measured by MTT colorimetric assay,
in accordance with [23]. Briefly, 100 μL of peritoneal
macrophages (5 × 105 cells/well) were added to 96-well
plates and incubated for 2 h, at 37 °C with 5 % CO2.
After that, 100 μL of the crude ethanolic extracts or
fractions of A. chica were added to the wells in serial
concentrations (600 to 0.97 μL/mL). For each concentra-
tion a negative control was maintained. Dimethyl sulfox-
ide (DMSO) was used as a control drug in serial
dilutions starting at 20 %. After 24 h of incubation, 5 μL
of MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide] was added to each well, then the
plates were incubated again for 2–4 h under the same
conditions. Later, they were centrifuged at 1500 xg and
200 μL of each well supernatant was discarded, before
100 μL of DMSO was added. Absorbance was measured
in a spectrophotometer, at a wavelength of 540 nm. 50 %
cellular cytotoxicity (CC50) was calculated using Graph-
Pad Prism 5.
In vitro antileishmanial activity
Parasites
The present study used the Leishmania amazonensis
(MHOM/BR/76/MA-76 – IOC/FIOCRUZ-RJ) strain, iso-
lated from a patient with diffuse cutaneous leishmaniasis
and maintained by serial passages in BALB/c mice, and
periodically re-isolated in culture medium. Promastigote
forms were grown at 26 °C in Schneider’s medium, sup-
plemented with 10 % fetal bovine serum, streptomycin
(100 μg/mL) and penicillin (100 μg/mL). To ensure infect-
ivity only cultures of promastigote with a maximum of
seven in vitro passages were used.
Before evaluation of leishmanicidal activity and deter-
mination of the 50 % inhibitory concentration (IC50) of
A. chica, a screening test was performed to determine
the concentration used in IC50 assay. The concentration
used ranged between 500 and 0.97 μg of crude ethanolic
extracts or fractions, diluted in 1 % DMSO, and added
to 96-well plates containing RPMI, serially and in tripli-
cate. Wells containing medium and parasites, medium
only, and the reference drug, Amphotericin B (2 μg/mL),
were used as controls. 100 μL of L. amazonensis promasti-
gotes in the logarithmic phase (1x106 parasites/mL) were
added to each well, and the plate was incubated at 26 °C.
Parasite viability was measured after 24, 48 and 72 h, by
observing motility under an inverted microscope. The par-
asites were classified according to mobility on a scale of
zero to ten, where zero means no viable forms and ten,
viable forms.
Based on the screening results the IC50 was determined,
following the same aforementioned protocol, and leishma-
nicidal activity was assessed by counting the viable parasites
in a Neubauer chamber. The data was then normalized
using the formula: Percentage of growth inhibition = num-
ber of parasites in test wells/number of parasites in the
control well, multiplied by 100; and used for statistical
analysis.
Wound healing activity
Cream and therapeutic protocol
Two topical preparations (10 mg/g and 20 mg/g) were
prepared containing the crude ethanolic extract from A.
chica leaves mixed with Lanette® cream, as a water-soluble
anionic vehicle.
Forty 4-to-6 week old male Swiss Webster mice from the
animal facility of the Universidade Estadual do Maranhão
(São Luís, Maranhão, Brazil) were used in this experiment.
The animals were randomly divided into two groups
(n = 20 each). The control group was treated with Lanette®
cream and the experimental group was treated with
Lanette® cream containing the crude ethanolic extract of A.
chica.
For creation of a dorsal skin wound, the animals were
anesthetized with an intraperitoneal injection of xylazine
hydrochloride (10 to 15 mg/kg) and ketamine hydro-
chloride (100 to 150 mg/kg). Trichotomy of the dorsal
region and demarcation of the skin with a punch was
then carried out. Resection of a circular segment of
approximately 6 mm diameter was performed, exposing
the dorsal fascia. Hemostasis was carried out by digital
compression with sterile gauze, with treatment initiated
immediately afterwards.
The therapeutic protocol was performed twice a day
throughout the experimental period. Transverse and
longitudinal diameters of the lesions were measured
daily, using a digital caliper, and monitored through pho-
tography. Skin wound areas were calculated using the
formula A = π x R x r, in which A represents the area, π
is equal to 3.14, R represents the largest diameter and r
the smallest diameter of the wound.
Histological analysis
After 3, 7, 14 and 21 days of treatment, the mice were eu-
thanized and the lesions were excised with a margin of
1 cm of integrate skin, stored in 10 % buffered formalin
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solution and submitted to histological procedures. After
embedding in paraffin, 5 μm thick cross sections were cut
and stained with hematoxylin-eosin (HE) for morpho-
logical analysis of the tissue. Additionally, fragments of
liver, spleen and kidney were collected, for evaluation of
potential cytotoxic lesions.
Slides were analyzed by light microscopy by two inde-
pendent examiners, following the parameters: crust for-
mation, presence of inflammatory infiltrate, angiogenesis,
reepithelialization and collagen formation [24]. These
features were graded as absent, mild, moderate and severe,
according to their appearance.
Statistical analysis
Statistical analysis was performed using GraphPad
Prism 5.0.4 (GraphPad Software Inc.). IC50 and CC50
values were calculated from the mean percentage reduction
of promastigotes and macrophages, respectively. Curves
were determined by application of sigmoidal regression to
logarithm concentration response data. In vitro results are
representative of three different experiments, performed in
triplicate, under the same temperature, CO2, time and cul-
ture medium conditions, with similar results. Analysis of
wound healing was performed using the Student’s t-test.
Histological variables were analyzed by non-parametric test.
Differences were considered significant at P < 0.05.
Results
Yield of extraction and phytochemical analysis
The crude ethanolic extracts of Arrabidaea chica leaves
and stem presented a yield of 59.2 and 3.33 % respect-
ively, which shows that the stem has a low extraction
efficiency, as the same extraction method was used for
both stem and leaves.
Phytochemical screening showed that both leaves and
stem extracts contain flavonoids, tannins, anthocyani-
dins and chalcones. Phenolic compounds were found
only in the leaves (Table 1).
IC50 determination
In screening tests to evaluate the potential leishmanici-
dal effect on L. amazonensis promastigotes, A. chica
stem extract showed no activity against the protozoan,
even at the highest tested concentration (500 mg/mL),
and so was not used in continuity tests.
In the screening tests of the crude ethanolic extract of
A. chica leaves, there was a reduction of 50 % of L. ama-
zonensis promastigote viability with a concentration of
125 μg/mL (Fig. 1) at the intervals of 24, 48 and 72 h
after incubation. However, the concentration of 250 μg/
mL displayed antileishmanial activity in the first 24 h of
treatment and a total absence of viable parasites after
72 h of incubation. The concentration of 500 μg/mL of
the leaf ethanol extract had the best leishmanicidal effi-
cacy at the three tested intervals.
After screening, the 50 % inhibitory concentration
(IC50) of L. amazonensis promastigote forms was deter-
mined as 155.9 μg/mL (Fig. 2).
When evaluating the leishmanicidal activity of the
chloroform, methanol and ethyl acetate fractions, there
was a 50 % reduction of L. amazonensis promastigotes at
concentrations of 120 μg/mL, 120 μg/mL and 60 μg/mL,
respectively (Table 2). This result demonstrated that the
fractions acted against the parasite at lower concentra-
tions than the crude extract, and that the ethyl acetate
fraction had the most effective result.
CC50 determination
Cytotoxicity assay in the peritoneal macrophages after
24 h showed that a 189.9 μg/mL concentration of A.
chica leaf extract reduced the number of viable cells by
50 %, representing CC50 (Fig. 3).
Regarding CC50 and IC50 values of the crude extract, it
was observed that A. chica’s bioactive compounds have a
higher Selectivity Index (1.218) to the parasite than to
the host cell, proving to be a potential treatment for
leishmaniasis.
Table 1 Phytochemical prospection of crude ethanolic extract
of leaves and stem of Arrabidaea chica, collected in Maranhão
state, Brazil
Metabolite class Reactions Arrabidaea chica
Leaves Stem
Anthraquinones NaOH - -




Saponin Foaming index - -
Phenolic compound FeCl3 + -
Tannin Gelatin + +
Anthocyanidins/chalcones HCl/NaOH + +
(+) presence; (−) absence
Fig. 1 Viability of Leishmania amazonensis promastigotes cultivated
in RPMI media at 24 °C and treated with crude extract of leaves of
Arrabidaea chica, at concentrations of 62.5 to 500 μg/mL. Score: (10)
viable, (5) less viable, (0) unfeasible
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Healing effect
Regarding the evaluation of dermal irritation potential of
the crude extract of A. chica leaves, a concentration of
20 mg/g caused skin irritation, with the presence of
moderate and persistent erythema during the treatment
period. Thus, the healing test was performed with a con-
centration of 10 mg/g.
In macroscopic analysis of the wound healing process,
the beginning of the tissue repair process, with the pres-
ence of crusts on the third day, was noted. On the sev-
enth day, a reduction in the size of the wound and the
formation of granulation tissue in both the treated and
control groups was observed (Fig. 4).
In the 0–3 day interval an increase in the lesion area
was observed in the group treated with A. chica, as com-
pared to the control group (Fig. 5). In the third to the
10th day, there was a marked reduction in the wound
area, with a gradual approximation of the edges in both
the control and treated groups.
Between the 14th and 21th post-injury days, the re-
traction of the wound was almost complete, with
marked healing and tissue repair.
On the third day of treatment cellular debris and mod-
erate to intense inflammatory process was observed in
both groups. Discrete angiogenesis, collagen deposition
and epithelialization were observed in the treated group
(Fig. 6a–b), as well as an increased amount of mast cells.
On the seventh day of treatment, re-epithelialization and
the reduction of cell debris and the inflammatory process
was quite evident. While there was no difference between
the two groups, the patterns of re-epithelialization, angio-
genesis and collagen deposition were higher in the control
group.
Healing process evaluation between the 14th and 21st
days showed epithelialization and intense collagen de-
position in the control group (Fig. 6c–d), while the
treated group (Fig. 6e–f ) revealed patterns ranging from
mild to intense. In both groups, there was a low number
of inflammatory cells and mast cells. Angiogenesis was
discreet in the treated group and varied from moderate
to mild between the 14th and the 21st day.
The topical preparation with the crude extract of A.
chica at a concentration of 10 mg/g displayed a more
effective healing activity in the initial phase of the ex-
periment, but was not able to induce a stronger response
throughout the 21 day observation period.
Discussion
Plants are important sources of bioactive compounds,
and are a major potential source of new therapeutic
agents against several diseases, including those of inter-
est to public health, in particular neglected diseases such
as leishmaniasis.
The bioactive compounds produced by plant cells may
vary depending on soil, climate and the season that the
plant, fruit or leaves were collected. Soil and climate
conditions, along with the plant’s need for adaptation
and defense, bring about this change in chemical constit-
uents [25]. Phytochemical analysis of A. chica revealed
the presence of flavonoids, tannins, anthocyanidins,
Fig. 2 In vitro leishmanicidal activity of the crude ethanolic extract
of Arrabidaea chica against Leishmania amazonensis promastigotes at
concentrations of 0.97 to 500 μg/mL
Table 2 50 % inhibitory concentration (IC50) of Leishmania
amazonensis promastigote forms after 72 h treatment with
crude ethanolic extract and chloroform, methanolic and ethyl
acetate fractions of Arrabidaea chica
Treatments IC50 (μg/mL)
Crude ethanolic fraction 155.9 ± 0.1185
Chloroform fraction >120
Methanolic fraction >120
Ethyl acetate fraction >60
Amphotericin B (reference drug) 0.76 ± 0.9218
Values represent mean ± standard deviation
Fig. 3 Cytotoxicity evaluation in peritoneal macrophages cultured
in RPMI medium, at 37 °C and 5 % CO2 and treated for 24 h with
ethanol extract of Arrabidaea chica leaves at concentrations of 0.97
to 500 μg/mL
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chalcones and phenolic compounds, as previously de-
scribed for this species [26, 27].
The first chemical study with the leaves of A. chica was
performed by Chapman et al. and reported the isolation of
the substance 3-deoxyanthocyanidin, more specifically
1,6,7-dihydroxy-5,4′-dimethoxy-flavylium (carajurin) and
6,7,4′-trihydroxy-5′, methoxy-flavyluim (carajurone), re-
sponsible for the reddish color of the extract [28]. In other
studies, other compounds, such as flavone acacetin, olea-
nolic triterpene acid and two deoxiantocyanidins (6, 7, 3′-
4′-tetrahydroxy-5-methoxy-flavylium and 6, 7, 3′-trihy-
droxy-5, 4′ dimethoxy-flavyliume) were isolated [29-31].
Anthocyanins are plant pigments belonging to the family
of flavonoids, included in the group of phenolic compounds
[32, 33]. More than 50 new anthocyanins have been isolated
from the flowers, fruits, seeds and leaves of plants. They
play a pivotal role in flower pollination, seed dispersal by
insects and defense against predatory insects [34].
Pharmacological studies with anthocyanins reveal their
high antioxidant effect [15] on metabolic diseases [35].
The antioxidant, cytotoxic, antimicrobial and diuretic
potential of the ethanol extract and fractions of A. chica
was evaluated by Amaral et al. that confirmed this anti-
oxidant and diuretic action, and the absence of an anti-
microbial and cytotoxic response [14]. The therapeutic
activity of the phenolic compounds is mainly attributed
to their antioxidant capacity, the chelation of metal ions,
modulation of gene expression and interaction with cell
signaling pathways [36].
Phenolic composition and antioxidant activity of the
leaves of A. chica was evaluated by Siraichi et al. by
liquid chromatography-electrospray ionization-tandem
mass spectrometry (LC-ESI-MS/MS), and verified the
presence of two important flavonoids, apigenin and
scutellarein, which are most responsible for the signifi-
cant antioxidant action [15].
In pharmacological tests, Alves et al. determined the
chemical potential of A. chica dye, which is widely used by
indigenous tribes, and verified the presence of alkaloids,
anthocyanidins, anthocyanins, anthraquinone, steroids,
triterpenoids, phenols, flavanonois, flavanols, flavanones,
saponins and catechin tannin [37]. This study described
some compounds undetected in the present study, differ-
ing in the presence of anthraquinones, steroids, triterpe-
noids and saponins. This fact is probably due to the
climate differences between the two places where the
plant was collected, the states of Maranhão and Pará, as
well as the method by which the extract was obtained.
Both were obtained using ethanol as a solvent; however, in
the present study this was submitted to 72 h rotoevapora-
tion at 40 °C, while in the aforementioned study the
extract was macerated for 10 days in a capped percolator.
In vitro pharmacological studies have demonstrated
the antineoplasic and antioxidant potential of A. chica,
and this action was directly related to the high content
of flavonoids, especially anthocyanins [38]. These and
other benefits made the search for new sources of an-
thocyanins essential [35].
The secondary metabolites in A. chica, such as flavo-
noids, the antimicrobial, antiviral, anti-inflammatory, anti-
neoplastic, antifungal and anti-protozoan action of which
has already been reported in literature [17, 38–40], en-
courages many researchers to study this plant.
In the present study, the leishmanicidal potential of
the crude extract and fractions of A. chica, which dis-
played satisfactory results at concentrations between 60
Fig. 4 Macroscopic evaluation of the healing process in Swiss mice
Webster treated with LANETTE® cream (Control Group) and ethanol
extract of Arrabidaea chica leaves (Experimental Group) over 21 days
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and 155.9 μg/ml, depending on the type of fraction. The
chemical constituents of the plant were more selective
for the protozoan than the host cell, with a cytotoxicity
effect at concentrations higher than those with leishma-
nicidal action.
Several studies have aimed to identify and characterize
crude extracts, fractions and essential oils [41-48], as well
as the isolated compounds of the plant [49, 50], with leish-
manicidal activity. The screening of these natural com-
pounds is performed with cultures of Leishmania spp., as
it is easy to maintain and produce [51].
According to the World Health Organization, a candi-
date drug must undergo in vitro cytotoxicity and anti-
parasitic activity testing. After this initial screening, the
results are evaluated to define the continuity of studies
and the possibility of in vivo assays [52].
Studies performed by Rodrigues et al. [53] investigated
the leishmanicidal effect of five fractions obtained from
the crude hexane extract of A. chica, on L. amazonensis
and L. infantum promastigote forms, by determining the
minimum inhibitory concentration (MIC), which was
found to be 37.2 and 18.6 μg/ml, respectively. This result
is related to one of the fractions used, the main chemical
components of which were linoleic acid methyl ester
(25.38 %), n-hexadecanoic acid (19.61 %), octadecanoic
acid (14.10 %) and gamma-sitosterol (12.85 %). The
study also evaluated ultrastructural alterations of the
parasite under the influence of this fraction, and ob-
served mitochondrial swelling, disruption of mitochon-
drial membrane, presence of vesicles in the cytoplasm,
mitochondria and flagellar pocket and modifications in
the Golgi complex.
The significant increase in studies of plant compounds
with leishmanicidal potential is due to of the major
importance of this disease, of which there are large num-
bers of new cases annually. According to the World
Health Organization 1.3 million new cases are recorded
per year, being 300,000 cases of visceral leishmaniasis
and 1 million cutaneous leishmaniasis [5].
Leishmaniasis are characterized as neglected diseases,
as they are associated with low social indicators and are
more prevalent in developing countries, whose resources
in the areas of control, treatment and research are insuf-
ficient [4].
Additionally, plant extracts or plant compounds can
represent a valuable source of new medicinal agents and
alternative, effective and less toxic treatments, compared
to conventional drugs (pentavalent antimoniates, ampho-
tericin B, pentamidine), leading to a search for natural
products with a potential leishmanicidal action. Further-
more, the benefits obtained from the search for natural
products have encouraged interest in valuable synthetic
compounds [42].
The crude extract from the leaves of A. chica had a
cytotoxic effect at a concentration of 189.9 μg/mL.
Maliofete et al. [54], also testing the ethanol extract from
the leaves of A. chica, observed low oral toxicity, absence
of cytotoxicity and antibacterial activity against Helico-
bacter pylori. In vivo experimental studies did not show
any clinical or histopathological signs of extract toxicity
in the pleura [13], open or sutured wounds or burns
[55]. Studies by Barbosa et al., assessing the antifungal,
antimicrobial and antiprotozoal potential of the ethano-
lic extract and fractions of A. chica, observed growth
inhibition of Trichophyton mentagrophytes and a signifi-
cant trypanocidal effect against Trypanosoma cruzi, as
well as the absence of relevant acute toxicity, even at the
highest dose tested (1000 mg/kg) [17].
Fig. 5 Wound healing kinetics of surgical lesions in Swiss Webster mice treated with Lanette® cream (Control Group) and ethanol extract of
Arrabidaea chica leaves (Experimental Group) over 21 days
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Several factors must be taken into consideration when
evaluating the toxic effects of a plant extract, such as sea-
sonal and environmental factors, the genotypic variations
of the species, the part of the plant used to produce the ex-
tract, the time of collection and the age of the plant [25].
In traditional medicine in the Amazon region, A. chica
is widely used as an anti-inflammatory, healing and anti-
anemic medicine, and is prepared from the leaves as a
tea, for oral or vaginal administration [16, 17, 56]. How-
ever, despite its wide popular use, several studies are still
necessary to evaluate the medical potential of this plant.
In the present study, the healing potential of the crude
extract of the leaves of A. chica in skin lesions was eval-
uated. A satisfactory response was initially observed,
with angiogenesis and collagen deposition, but over the
21-day observation period it was found that the extract
did not accelerate healing, presenting a similar profile to
the control group.
Several local and systemic factors can cause variations
in the healing process, leading to a delay or even pro-
longation of healing. Among these are the local of the
lesion, existence of infection, surgical technique, tissue
ischemia and bandages, as well as malnutrition and/or
deficiency of trace minerals and vitamins [57, 58].
As cited above the importance of bandages in the
healing process should be noted. Several studies have
demonstrated that there the healing process is more suc-
cessful when bandages are placed on the location of the
wound after the application of the test product [16, 59]
to protect the injury area. This step, which was not per-
formed in the present study, may have contributed to
the retardation of healing. The application of a suitable
compress enables an increase of the natural debridement
and simplifies healing, as it keeps the exudates rich on
mediators on the wound surface [60].
Wound healing is a complex and dynamic process of
the replacement of a devitalized tissue by a new tissue,
which occurs through a series of biochemical cascade
events; usually divided into three phases: the inflamma-
tory, proliferative, and remodeling phases [61]. Wound
healing treatment has improved considerably over time,
notably in order to achieve the best scarring results in
the shortest possible time.
In the present study, a strong inflammatory response
was observed at the beginning of the healing process,
with an increased lesion area until the 3rd day after
surgical incision and the presence of inflammatory cells
in histological evaluation. The inflammatory phase is
characterized by increased vascular permeability and im-
mune cells chemotaxis to the site of injury, due to the
release of mediators (histamine, serotonin, bradykinin,
prostaglandins, thromboxanes) [62].
The most pronounced reduction period in the wound
area was between the third and the 10th day, with retrac-
tion of the wound area, representing the proliferative
phase. During this phase fibroplasia, granulation tissue
formation, and removal of cellular debris were observed,
with the formation of a temporary repair tissue during in-
flammation, and development of tissue substitutes [63].
In the healing process, fibroplasia occurs together with
neovascularization [61]. As the wound healing process
advances, fibroblasts undergo phenotypic changes, with
an abundance of rough endoplasmic reticulum, due to
intense protein synthesis; and subsequent transformation
into myofibroblasts, which help in the retraction of the
lesion [64, 65].
Studies performed by Jorge et al. [16], when evaluating
the healing, anti-inflammatory, antiulcerogenic and antioxi-
dant effect of crude methanolic extract of A. chica, found
that there was no reduction of paw edema induced by car-
rageenan or ear edema induced by croton oil in rats. How-
ever, in vitro fibroblast proliferation induction, stimulation
Fig. 6 Swiss Webster. Skin. Healing process through topical
treatment with a cream containing the crude ethanolic extract
of A. chica (experimental group) or only Lanette® cream (control group).
a (3 days) - Experimental group: cellular debris (Δ), reepithelization
(arrow), angiogenesis (*). b (7 days) - Experimental group:
Absence of cellular debris and angiogenesis (*). c (14 days) and
(d) (21 days) - Control group: Absence of cellular debris and
reepithelization. e (14 days) and (f) (21 days) - Experimental group:
Absence of cellular debris and reepithelization. HE
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of collagen synthesis in vivo and in vitro, anti-ulcer activity
and moderate antioxidant capacity were observed.
After 10 days, it was verified that 96 % of wounds in
the experimental group had healed, with a prominent
collagen deposition, while in the control group, treated
with saline solution, only 36 % of the wounds had
healed, with a mild collagen deposition [16].
The topic healing effect of A. chica extract in the ten-
dons of Wistar rats was investigated by Aro et al., that
found better collagen organization in the treated groups
than in the control group, as well as an increase in sulfate,
on the 14th day treatment [20].
Compounds exhibiting antioxidant activity can indicate
good therapeutic agents in the healing process, according
to Houghton et al. [57]. Non-enzymatic antioxidant activity
is promoted by flavonoids, carotenoids, ascorbic acid, gluta-
thione, and vitamin E, among others [58, 66, 67]. Therefore,
the healing activity of A.chica is attributed to the antioxi-
dant activity of anthocyanins and to fibroblast proliferation
stimuli and consequent collagen synthesis [16, 68].
Fibroblasts are connective tissue cells, essential for der-
mis formation, due to collagen production, and respon-
sible for structural firmness. After tissue injury, fibroblasts
near the lesion site proliferate, migrate to the wound and
produce a large amount of matrix material rich in collagen
(type I and III), which helps to isolate and repair the
injured tissue [63].
The proliferation of fibroblasts is directly related to
the presence of macrophages in the healing process, as
these release growth factors and cytokines essential for
the maturation of the inflammatory phase and the begin-
ning of the healing. Among the growth factors respon-
sible for the proliferation, insulin-like growth factor 1
(IGF-I) and transforming growth factor beta (TGF-β)
play an important role. Studies have demonstrated that
IGF-I increases the procollagen chain expression in
cultured dermal fibroblasts [63].
In the present study, on day 14 the control and ex-
perimental groups presented a smaller healing area
than on day 07. At the end of the experiment, after
21 days, both groups were in the final stages of the
healing process, in which the remodeling phase pre-
dominates, characterized by the reduction of inflamma-
tory cells [69] and blood vessels at the lesion site [61],
being the stage in which the scar acquires maximum
resistance [70].
Several plants are used in popular medicine for the
treatment of skin disorders. A number of these, such as
Aloe vera (“babosa”), Schinus terebenthifolius (“aroeira”),
Stryphnodendrom barbatiman (“barbatimão”), Calendula
officinalis (“calendula”) and Triticum vulgare (“trigo”) are
especially worthy of note due to the number of Brazilian
studies involving the phytopharmaceutical use of these
species [71–74].
Conclusions
The present study demonstrates that the compounds
extracted from A. chica leaves are potential leishmanici-
dal agents in non-cytotoxic concentrations, with further
research required to continue the evaluation of this
potential, in order to develop new drugs based on these
compounds, or associate them with drugs already used
in therapeutic protocols for the disease. The wound
healing potential of the plant requires additional studies,
in order to eliminate the interference of external factors
and optimize the action of A. chica extract.
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